SEC Form 5 · accession 0001387131-16-004279
TherapeuticsMD, Inc. · TXMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John C.K. Milligan IV
Officer — President/Secretary · Director
Period of report
Dec 31, 2015
Accepted (ET)
Feb 16, 2016 · 9:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000025743
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Dec 26, 2015 | G | 50,000 | $0.00 | D | 2,790,396 | I | See |
| Common Stock | holding | — | — | — | 1,472,419 | D | ||
| Common StockF1 | holding | — | — | — | 1,321,791 | I | See |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1By grantor-retained annuity trust.
- F2Includes 20,000 shares of common stock previously reported as being held directly by Mr. Milligan and 178,209 shares of common stock previously reported as being held indirectly by grantor-retained annuity trust.
- F3By John C.K. Milligan Revocable Trust U/A 08/10/2009, as amended.